Press Release
Article Category
![Dapagliflozin](https://parsianpharma.com/wp-content/uploads/2024/01/Benefits-of-Dapagliflozin.jpg)
Dapagliflozin in Patients with Type 2 Diabetes
Benefits of Dapagliflozin When in Patients with Type 2 Diabetes Abstracts Dapagliflozin reduces the
![Type 2 diabetes](https://parsianpharma.com/wp-content/uploads/2024/01/Type-2-Diabetes-.jpg)
Understanding Type 2 Diabetes and Medications for Management
Type 2 diabetes is a prevalent chronic condition, that affects millions of people
![Risk of Developing Diabetes](https://parsianpharma.com/wp-content/uploads/2024/01/Untitled-1.jpg)
increase Risk of Developing Diabetes
COVID-19 infection even mild ones may increase Risk of Developing Diabetes A recent
![Empagliflozin](https://parsianpharma.com/wp-content/uploads/2024/01/Untitle222d-1.jpg)
US FDA Approved Empagliflozin
The U.S. FDA Approved Empagliflozin for Wider Range of Patients with Heart Failure
![Type 2 Diabetes Mellitus](https://parsianpharma.com/wp-content/uploads/2024/01/Diabetes-.jpg)
Type 2 Diabetes Mellitus
Overview of Type 2 Diabetes Mellitus Type 2 diabetes mellitus is the most common